# A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis

> **NCT06073119** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 221 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** SAR441566
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06073119
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-26
- **Primary completion:** 2024-11-13
- **Final completion:** 2024-12-11
- **Target enrollment:** 221 (ACTUAL)
- **Last updated:** 2025-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06073119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06073119, "A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06073119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*